OPEN IN READ APP
JOURNAL ARTICLE
REVIEW

Pharmacotherapy of vertigo: any news to be expected?

H Timmerman
Acta Oto-laryngologica. Supplementum 1994, 513: 28-32
7910713
Despite the introduction of new medicinal agents for the treatment of vertigo, no new pharmacological entities have been established. For several years all "new" products have belonged to the well established pharmacological classes of antihistamines (H1-antagonists), calcium-entry inhibitors or vasodilators. In this article these pharmacological classes will be briefly reviewed, with special emphasis given to the pre-synaptic histamine receptor (H3), a recently established pharmacological function. Compounds interfering with this receptor, especially the antagonists, seem to offer new ways of treating vertigo and possibly also new ways of developing new therapeutic agents.

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Trending Papers

Available on the App Store

Available on the Play Store
Remove bar
Read by QxMD icon Read
7910713
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"